Vectibix
5 Topics Found
Panitumumab
Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans). Panitumumab is manufactured by Amgen and marketed as Vectibix. It was originally developed by Abgenix Inc. In 2014, Amgen and Illumina entered into an agreement to develop a companion diagnostic to accompany panitumumab.[1] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Phar...
Drug Index
Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans). Panitumumab is manufactured by Amgen and marketed as Vectibix. It was originally developed by Abgenix Inc. In 2014, Amgen and Illumina entered into an agreement to develop a companion diagnostic to accompany panitumumab.[1] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Phar...
NDC Database
Vectibix 100 mg/5ml Intravenous Solution by Amgen Inc ## Package Codes: 55513-954-01 ## Active Ingredients: Panitumumab
NDC Database
Vectibix 200 mg/10ml Intravenous Solution by Amgen Inc ## Package Codes: 55513-955-01 ## Active Ingredients: Panitumumab
NDC Database
Vectibix 400 mg/20ml Intravenous Solution by Amgen Inc ## Package Codes: 55513-956-01 ## Active Ingredients: Panitumumab